Brief: Milestone Pharmaceuticals Provides 2025 Corporate Outlook And To Host Investor Event On Feb 25 In NYC
28/01/2025 13:05
Jan 28 (Reuters) - Milestone Pharmaceuticals Inc
MIST.O :
* MILESTONE PHARMACEUTICALS PROVIDES 2025 CORPORATE OUTLOOK
AND
WILL HOST INVESTOR EVENT ON FEBRUARY 25 IN NYC
* MILESTONE PHARMACEUTICALS INC: PDUFA DATE OF MARCH 27,
2025 FOR
CARDAMYST™ (ETRIPAMIL) NASAL SPRAY
* MILESTONE PHARMACEUTICALS INC: PLANS TO INITIATE PHASE 3
STUDY
IN AFIB-RVR IN H1 2025
Source text: ID:nGNX52zbjR
Further company coverage: MIST.O
(((( Reuters.briefs@thomsonreuters.com ;));))
Recent news on Milestone Pharmaceuticals
See all newsBrief: Milestone Pharmaceuticals Announces First European Study Participant Enrolled In Revera-301 Phase 3 Clinical Trial
Brief: Milestone Pharmaceuticals Says NMPA Approval Triggers $2 Mln Milestone Payment To The Co
Milestone Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Canada's Milestone Pharma misses Q2 product revenue expectations
Milestone Pharmaceuticals Inc expected to post a loss of 19 cents a share - Earnings Preview